home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

Cardiovascular Safety of Oral and Injectable Diabetes Medications

 
  September 28, 2017  
     
 
Netzealous LLC -MentorHealth, Online
2017-10-31


Training Options  Duration: 60 Minutes  
Tuesday, October 31, 2017   |   10:00 AM PDT | 01:00 PM EDT

Overview: This webinar will review the cardiovascular outcome trial data, evaluate the possible benefits and risks of therapy, and apply information to clinical practice.

Why should you Attend: Diabetes affects 30.3 million Americans, which is approximately 9.4% of the population. Uncontrolled diabetes results in multiple microvascular and macrovascular complications, such as increased risk of heart disease, heart attack and stroke. In 2015, diabetes remained the 7th leading cause of death in the United States. According to the American Diabetes Association and Centers for Disease Control, Atherosclerotic Cardiovascular disease (ASCVD) is the leading cause of morbidity and mortality for individuals with diabetes. ASCVD is a large contributor to the health care costs of diabetes. 

Diabetes is an independent risk factor for cardiovascular disease, with many of those persons having elevated blood pressure and elevated lipid levels. Therefore, it is essential to evaluate the cardiovascular safety of medications used to treat diabetes. There are several newer oral options for diabetes therapy, such as Dipeptidyl peptidase-4 (DPP-4) inhibitors and Sodium glucose cotransporter-2 (SGLT2) inhibitors; and injectable agents such as Glucagon-Like peptide-1 (GLP-1) receptor agonists. Various cardiovascular outcome trials evaluating oral and injectable diabetes medications have recently been published. 

Areas Covered in the Session:

Macrovascular and microvascular complications of uncontrolled diabetes
Review of cardiovascular outcome trials for oral diabetes medications
Review of cardiovascular outcome trials for injectable diabetes medications

Who Will Benefit:
Physicians
Diabetes Educators
Nurses
Pharmacists

Speaker Profile 
Daphne Smith Marsh is a Doctor of Pharmacy and Certified Diabetes Educator, who currently is a Clinical Pharmacist and Clinical Assistant Professor at the University of Illinois College of Pharmacy in Chicago. Her clinical experience for the past 16 years includes provision of chronic disease education and co-management in the Internal Medicine, Endocrinology, Medication Therapy Management and Mile Square Health Clinics. Dr. Smith Marsh has been an invited speaker for national organizations, and has published in peer-reviewed national and international journals. Her research interests include diabetes education and medication adherence, particularly in the African American and Hispanic communities.

Price - $139
Contact Info:
Netzealous LLC -MentorHealth
Phone No: 1-800-385-1607
Fax: 302-288-6884 
Email: support@mentorhealth.com
Website: http://www.mentorhealth.com/
Webinar Sponsorship: https://www.mentorhealth.com/control/webinar-sponsorship/

 
 
Organized by: Netzealous -MentorHealth
Invited Speakers: Daphne Smith Marsh is a Doctor of Pharmacy and Certified Diabetes Educator, who currently is a Clinical Pharmacist and Clinical Assistant Professor at the University of Illinois College of Pharmacy in Chicago. Her clinical experience for the past 16 years includes provision of chronic disease education and co-management in the Internal Medicine, Endocrinology, Medication Therapy Management and Mile Square Health Clinics. Dr. Smith Marsh has been an invited speaker for national organizations, and has published in peer-reviewed national and international journals. Her research interests include diabetes education and medication adherence, particularly in the African American and Hispanic communities.
 
Deadline for Abstracts: 2017-10-30
 
Registration: http://www.mentorhealth.com/control/w_product/~product_id=801107LIVE?hum-molgen.org_oct_2017_SEO
E-mail: support@mentorhealth.com
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.